Meta-analysis finds some ivermectin benefits in COVID-19 patient
An analysis published in Open Forum Infectious Diseases found a 56% reduced risk of mortality for COVID-19 patients taking the anti-parasitic drug ivermectin compared to standard of care or another therapy. The study pulled data from 24 randomized trials involving 3,328 patients with moderate to severe COVID-19. The study also found that ivermectin was “associated […]
